InvestorsHub Logo
Followers 132
Posts 8935
Boards Moderated 2
Alias Born 06/01/2013

Re: None

Friday, 01/03/2025 3:51:52 PM

Friday, January 03, 2025 3:51:52 PM

Post# of 33346
$ENDV SofPulse, a FDA Cleared medical device company specializing in non-invasive microcurrent therapy, has undergone several valuations in recent years:

2018 Valuation: A third-party assessment valued SofPulse's intellectual property and assets at $75 million.

2023 Agreement: Endonovo Therapeutics, the parent company, entered into a definitive agreement to sell SofPulse's business and medical intellectual property to SofPulse, Inc. for a minimum of $50 million. The final purchase price is subject to an updated valuation by a qualified third party, with estimates ranging between $50 million to $100 million.